Pharmacists in Hoffman Estates, IL Accepting Medicare
66 Pharmacists found. Showing 61 - 66
 Suzanna Kwong Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2012 Bonita Ln, Hoffman Estates, IL 60192 Phone: 847-637-1963 |
 Nikil Patel, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5429 Swan Cir, Hoffman Estates, IL 60192 Phone: 847-488-9353 |
Dr. David Joel Plumley, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2800 N Sutton Rd, Hoffman Estates, IL 60192 Phone: 847-645-1194 Fax: 847-645-1184 |
Dr. Sophie Cotseones Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1489 Palatine Rd, Hoffman Estates, IL 60192 Phone: 847-202-9232 Fax: 847-202-1227 |
Dianne Katrina Gumahad Usana, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1391 Bison Ln, Hoffman Estates, IL 60192 Phone: 224-634-8580 |
Kristin A Thomas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 N Roselle Rd, Hoffman Estates, IL 60169 Phone: 847-882-7240 |
News Archive
Waters introduces new TQ-S and G2 QTof mass spectrometers for Xevo MS platform
Waters Corporation introduced today two new mass spectrometers for its Xevo MS platform – the Xevo TQ-S and Xevo G2 QTof – that bring a step change in performance to benchtop mass spectrometry. The product introductions were made at the 58th annual meeting of the American Society for Mass Spectrometry (ASMS).
Corporate restructuring announced by Akela Pharma to achieve several operational objectives
Akela Pharma, Inc., (TSX: AKL) and its wholly owned manufacturing subsidiary, PharmaForm, today announced a comprehensive corporate restructuring designed to achieve several operational objectives.
Scientists find ways to block nitration of amino acids to improve cancer immunotherapy
Immunotherapy - harnessing T-cells to attack cancer cells in the body - has given hope to patients who endure round after round of treatment, including chemotherapy, to little effect. For all of its promise, however, immunotherapy still benefits only a minority of patients - a reality driving research in the field for ways to improve the relatively new approach.
Astellas to present positive AGS-1C4D4 phase II data in metastatic pancreatic cancer at ASCO 2011
Astellas Pharma Global Development, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, today announced that it will be presenting data from a phase II study evaluating AGS-1C4D4 in metastatic pancreatic cancer in a poster session at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago.
Auto-injector developed for women undergoing fertility treatment
A new auto-injector concept has been designed by innovative product development firm Cambridge Consultants in a bid to ease the trauma for women undergoing fertility treatment.
› Verified 5 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Psychologists
Occupational Therapists